BF

Bullfrog AI Holdings, Inc.

BFRGHealthcareNASDAQ

Health Information Services

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$116,670
Net Income
-$6.5M
+7.1% YoY
EBITDA
-$6.5M
+6.9% YoY
Free Cash Flow
-$3.3M

Scan Results

Daily timeframe
1 recent day hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 3 MACD Negative CrossoverHistogram -0.0052, negative momentum
Sep 2 MACD Negative CrossoverHistogram -0.0035, negative momentum
About Bullfrog AI Holdings, Inc.

Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. With a market capitalization of $9.3M, it sits in micro-cap territory. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations.

Where BFRG stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, BFRG finished 27.94% below its 150-day moving average ($0.68) and 33.78% below its 200-day moving average ($0.74). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is BFRG overbought or oversold?

At the September 3, 2026 close, BFRG's RSI(14) was 32.6, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$9.3M
Fwd P/E-2.96
EPS$-0.47
Beta-2.72
52W Change-63.7%
ROE-130.7%
Analysis

With $6.9M in cash and $90K in debt, BFRG maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company is burning cash, with free cash flow at -$3.3M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. ROE of -130.7% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $10K (2022) to $117K (2025), reflecting a 1067% increase over the period.

The relatively low beta of -2.72 suggests BFRG is a less volatile holding compared to the broader index. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Bullfrog AI Holdings, Inc. and its sector.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms